Heart Block

Heart block is a cardiac conduction disorder in which electrical signals move slowly or fail to pass from the atria to the ventricles, disrupting the heart’s normal rhythm and pumping coordination. It usually results from impaired conduction through the atrioventricular node or the His-Purkinje system and is classified as first-, second-, or third-degree block according to the extent of signal interruption. In biology and medicine, studying heart block helps explain how specialized cardiac cells coordinate contraction and how conduction pathways fail. Electrocardiography identifies characteristic timing changes, while severe cases may require an artificial pacemaker to maintain an appropriate heart rate.

Heart Block - Related Videos

Education

JoVE Core - Pharmacology

Heart Failure Drugs: β-Blockers

0 Views •

2024

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...

Research

JoVE EoE - Neurotherapeutics

Intravenous Delivery of Receptor Blockers to Reduce Brain Edema in a Mouse Model

0 Views •

2025

Source: Zeynalov, E. et. al., Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema. J. Vis. Exp. (2016)This video demonstrates the intravenous delivery of an arginine-vasopressin (AVP) receptor antagonist in a mouse model. Transient middle cerebral artery occlusion induces brain edema. An AVP receptor antagonist is administered through a catheter in the left jugular vein, alleviating edema.

Research

JoVE Journal - Medicine
Free Sample

Implantation of Total Artificial Heart in Congenital Heart Disease

0 Views •

Cited by 40 •

2014

This is a case report of a patient with congenitally corrected transposition of the great arteries (CCTGA) who received a total artificial heart (TAH) as a bridge to heart transplant. The TAH was successfully implanted with modifications to accommodate the patient's congenitally malformed heart.

Assessing Muscle Contraction with Neuromuscular Blocker Treatment

0 Views •

2025

This video demonstrates assessing the muscle using cultured motor neurons, Schwann cells, and myotubes, followed by treatment with a neuromuscular blocker to inhibit contraction. Color-coded time-motion graphics show a color-coded time-motion graphic. Red indicates the fastest movement, and blue indicates the slowest.

Depolarizing Blockers: Pharmocokinetics

0 Views •

2023

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...

View All Results

FAQs

Related Topics